Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2004 or most recent year available – Part (ii) Primary drug type used by clients (percent of all clients) and of those, the percent injecting it

Country

Opioids

% inj

Cocaine

% inj

Amphet-
amines

% inj

Ecstasy

Hallucin-
ogens

% inj

Cannabis

Others

Belgium

(1)

33.2

37.7

6.0

11.0

12.0

6.0

1.0

0.0

 

15.0

32.8

Czech Republic

 

24.5

86.4

0.2

16.7

54.2

84.9

0.4

0.2

0.0

16.5

4.0

Denmark

 

47.2

19.3

4.8

9.2

6.5

4.6

1.0

0.0

 

26.8

13.7

Germany

(2)

52.3

 

5.9

 

6.0

 

 

0.2

 

30.2

5.4

Greece

 

88.7

49.8

2.2

7.4

0.1

0.0

0.3

0.1

0.0

7.0

1.6

Spain

(3)

59.0

24.0

26.0

9.0

1.0

9.0

1.0

0.1

14.0

11.0

1.9

France

(4)

70.6

 

5.8

 

0.3

 

1.1

0.3

 

17.6

4.3

Ireland

(5)

59.1

57.8

5.3

12.8

0.7

2.9

4.4

0.1

0.0

27.7

2.7

Italy

 

73.4

41.0

9.2

5.0

0.1

0.0

0.7

0.1

12.0

13.2

3.3

Cyprus

 

66.7

79.5

8.9

0.0

0.0

 

2.9

0.2

0.0

20.8

0.5

Latvia

 

52.6

83.9

0.8

25.0

12.0

63.9

1.4

1.8

0.0

3.3

28.1

Lithuania

(6)

79.0

 

0.1

 

2.4

 

 

0.2

 

1.0

17.3

Luxembourg

 

79.0

70.0

11.0

58.0

0.6

 

1.4

0.3

 

5.4

2.3

Hungary

 

14.4

71.0

0.8

14.2

4.1

20.9

3.1

0.5

0.0

32.3

44.8

Malta

 

83.5

73.6

5.8

15.2

0.2

 

2.9

0.2

 

7.4

0.0

Netherlands

 

29.4

9.5

36.6

0.9

4.1

2.9

1.1

0.8

2.7

24.9

3.1

Austria

(7)

100.0

100.0

0.0

 

0.0

 

0.0

0.0

 

0.0

0.0

Poland

(8)

23.3

 

0.9

 

8.9

 

 

0.6

 

3.0

63.3

Portugal

(9)

 

 

 

 

 

 

 

 

 

 

 

Slovenia

(10)

84.6

71.5

1.7

31.6

0.2

0.0

0.5

0.0

 

12.7

0.4

Slovakia

 

42.6

77.4

0.5

0.2

24.7

40.6

0.2

0.8

5.5

17.2

14.1

Finland

 

39.0

84.8

0.1

 

30.4

78.2

0.4

0.1

 

20.4

9.6

Sweden

 

31.5

63.7

2.1

3.3

35.0

58.9

0.5

0.1

0.0

19.5

11.3

United Kingdom

(11)

71.0

51.0

9.0

7.0

3.5

33.0

0.8

0.1

13.0

11.0

4.6

Bulgaria

 

95.9

79.6

0.1

0.0

0.3

0.0

0.1

0.0

 

2.8

0.8

Romania

 

55.3

82.0

0.2

0.0

0.2

0.0

0.5

0.2

0.0

15.1

28.5

Turkey

 

43.6

19.8

4.7

0.1

0.0

 

6.3

0.0

 

22.6

22.8

Notes:

Data are not available for: Estonia, Norway.

Injecting as a route of administration is not reported for ecstasy, cannabis and other drugs.

When proportion of clients by main drug is 0, % of injectors is empty.

(1) Last data available refer to 1999.

(2) Data on amphetamines include amphetamines and ecstasy. Data on injection not available. Data taken from ST.04.

(3) Last data available refer to 2002.

(4) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003.

(5) Last data available refer to 2003.

(6) Data on amphetamines include amphetamines and ecstasy.

(7) Data refer to clients in substitution treatment only; figures for opiates as main drug and injecting use are 100 %.

(8) Last data available refer to 2003. Amphetamines include amphetamines + ecstasy.

(9) The total number of clients is available for 2003. No data available for 2004.

(10) Data refer to outpatient treatment centres and prison.

(11) Data relate to the period from 1 April 2003 to 31 March 2004 for UK.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2005 Reitox national reports - Standard Table 3 (see Table TDI-1 for details on sources)

Data filter | tditab05b-en.xml